Caladrius Biosciences, Inc. (CLBS)

Oncology Corporate Profile

Stock Performance

3.8715
0.1715

3 Month Stock History Chart

HQ Location

420 Lexington Avenue, Suite 350
New York, NY 10170

Company Description

Caladrius Biosciences, Inc. (Caladrius, formerly NeoStem) is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. Caladrius is a cell therapy leader with late-stage clinical programs based on a proprietary platform technology for immuno-oncology, as well as additional platform technologies for ischemic repair and immunomodulation, and capabilities that support other cell therapy developers. This integrated approach supports the industry in bringing significant life-improving medical treatments to market.

Website: http://www.caladrius.com/

This company does not have any commercial products

This company does not have any pipeline products

Source: http://www.caladrius.com/

Recent News Headlines

8/21/2017 06:18 am

8/21/2017 06:18 am

8/21/2017 06:18 am

8/16/2017 12:17 pm

8/13/2017 12:17 pm

8/10/2017 12:17 pm

8/10/2017 12:17 pm

8/10/2017 12:17 pm

8/10/2017 12:17 pm

8/10/2017 06:17 am

8/7/2017 06:18 am

8/3/2017 06:18 am

8/3/2017 06:18 am

7/30/2017 06:17 am

7/12/2017 12:18 pm

7/9/2017 12:18 pm

6/26/2017 06:17 am

6/14/2017 06:17 am

6/14/2017 06:17 am

6/1/2017 06:18 am

5/31/2017 06:17 am

5/24/2017 12:17 pm

5/23/2017 06:17 am

5/22/2017 06:17 am

5/18/2017 12:17 pm